Bank of New York Mellon’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.87M | Buy |
|
|||||
|
2025
Q2 | $1.94M | Buy |
|
|||||
|
2025
Q1 | $1.51M | Buy |
|
|||||
|
2024
Q4 | $1.28M | Sell |
|
|||||
|
2024
Q3 | $1.88M | Sell |
|
|||||
|
2024
Q2 | $3.93M | Buy |
|
|||||
|
2024
Q1 | $2.42M | Sell |
|
|||||
|
2023
Q4 | $2.42M | Sell |
|
|||||
|
2023
Q3 | $876K | Sell |
|
|||||
|
2023
Q2 | $1.45M | Buy |
|
|||||
|
2023
Q1 | $801K | Sell |
|
|||||
|
2022
Q4 | $2.28M | Buy |
|
|||||
|
2022
Q3 | $2.19M | Buy |
|
|||||
|
2022
Q2 | $1.33M | Buy |
|
|||||
|
2022
Q1 | $1.92M | Sell |
|
|||||
|
2021
Q4 | $2.15M | Buy |
|
|||||
|
2021
Q3 | $3.42M | Buy |
|
|||||
|
2021
Q2 | $4.43M | Buy |
|
|||||
|
2021
Q1 | $3.96M | Sell |
|
|||||
|
2020
Q4 | $2.94M | Buy |
|
|||||
|
2020
Q3 | $1.23M | Sell |
|
|||||
|
2020
Q2 | $2.22M | Buy |
|
|||||
|
2020
Q1 | $311K | Sell |
|
|||||
|
2019
Q4 | $414K | Sell |
|
|||||
|
2019
Q3 | $135K | Buy |
|
|||||
|
2019
Q2 | $80K | Sell |
|
|||||
|
2019
Q1 | $254K | Buy |
|
|||||
|
2018
Q4 | $117K | Sell |
|
|||||
|
2018
Q3 | $553K | Sell |
|
|||||
|
2018
Q2 | $521K | Buy |
|
|||||
|
2018
Q1 | $471K | Buy |
|
|||||
|
2017
Q4 | $544K | Buy |
|
|||||
|
2017
Q3 | $642K | Sell |
|
|||||
|
2017
Q2 | $928K | Buy |
|
|||||
|
2017
Q1 | $292K | Sell |
|
|||||
|
2016
Q4 | $553K | Buy |
|
|||||
|
2016
Q3 | $666K | Buy |
|
|||||
|
2016
Q2 | $487K | Buy |
|
|||||
|
2016
Q1 | $463K | Buy |
|
|||||
|
2015
Q4 | $715K | Buy |
|
|||||
|
2015
Q3 | $201K | Buy |
|